Evaluation of Antiglaucoma Drug Treatment Awareness and Patient-reported Medication Adherence: Determinants of Glaucoma Management

Overview

Journal J Postgrad Med

Specialty General Medicine

Date 2023 Jun 14

PMID 37313943

Authors

R K Tripathi

A Shah

S V Jalgaonkar

S Kerkar

Affiliations

Soon will be listed here.

Abstract

Introduction: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perceived drug adherence, and prescription patterns in POAG patients.

Methodology: This was a cross-sectional, single-center, questionnaire-based study conducted in the ophthalmology out patient department of a tertiary care hospital from April 2020 to November 2021. Patients of either gender, aged 40-70 years, with a confirmed diagnosis of POAG, who had records of POAG medications for at least last 3 months and who provided written informed consent, were included. Prescription details were recorded, and subsequently, patients were administered a pre-validated drug treatment awareness (14 items) questionnaire, a self-reported medication adherence (9-item) questionnaire, and then they performed eye drop instillation in a simulated setting.

Results: The total number of patients enrolled was 180, which yielded 200 prescriptions. The mean drug treatment awareness score was 8.18 ± 3.30, and 135 (75%) patients scored more than 50% (≥7/14). Similarly, 159 patients (83.33%) had scored >50% (i.e. >5/9), with a mean score of 6.30 ± 1.70 in the medication treatment adherence questionnaire. The mean eye drop instillation performance score was 7.18 ± 1.20. The 200 POAG prescriptions containing 306 drugs were analyzed, with beta blockers (184/200, 92%) and timolol (168/200, 84% encounters) being the highest prescribed classes/drugs.

Conclusion: POAG patients did have adequate treatment awareness with good self-reported medication adherence and performance of eye drop instillation technique. Around 25% patients lacked awareness; hence, reinforcement education programs on medication regimens need to be implemented.

Citing Articles

1. Study designs for making most of the limited resources.

Indrayan A J Postgrad Med. 2024; 70(4):227-231.

PMID: 39660579 PMC: 11722713. DOI: 10.4103/jpgm.jpgm_607_24.

Self-management challenges and support needs among patients with primary glaucoma: a qualitative study.

Hua Y, Lu H, Dai J, Zhou Y, Zhou W, Wang A BMC Nurs. 2023; 22(1):426.

PMID: 37957705 PMC: 10644434. DOI: 10.1186/s12912-023-01527-y.

References

Yadav A, Patel V . Drug use in primary open angle glaucoma: a prospective study at a tertiary care teaching hospital. Indian J Pharmacol. 2013; 45(2):117-20. PMC: 3660920. DOI: 10.4103/0253-7613.108279. View

Rajurkar K, Dubey S, Gupta P, John D, Chauhan L . Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018; 30(2):125-129. PMC: 6033778. DOI: 10.1016/j.joco.2017.09.002. View

Carroll S, Gaskin B, Goldberg I, Danesh-Meyer H . Glaucoma prescribing trends in Australia and New Zealand. Clin Exp Ophthalmol. 2006; 34(3):213-8. DOI: 10.1111/j.1442-9071.2006.01196.x. View

Singh K, Shrivastava A . Medical management of glaucoma: principles and practice. Indian J Ophthalmol. 2010; 59 Suppl:S88-92. PMC: 3038497. DOI: 10.4103/0301-4738.73691. View

Tatham A, Sarodia U, Gatrad F, Awan A . Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013; 27(11):1293-8. PMC: 3831141. DOI: 10.1038/eye.2013.187. View

Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11):2081-90. DOI: 10.1016/j.ophtha.2014.05.013. View

Tenkir A, Solomon B, Deribew A . Glaucoma awareness among people attending ophthalmic outreach services in Southwestern Ethiopia. BMC Ophthalmol. 2010; 10:17. PMC: 2889880. DOI: 10.1186/1471-2415-10-17. View

Gupta R, Patil B, Shah B, Bali S, Mishra S, Dada T . Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2011; 21(3):189-92. DOI: 10.1097/IJG.0b013e31820bd2e1. View

Arbabi A, Bao X, Shalaby W, Razeghinejad R . Systemic side effects of glaucoma medications. Clin Exp Optom. 2021; 105(2):157-165. DOI: 10.1080/08164622.2021.1964331. View

10.

Djafari F, Lesk M, Harasymowycz P, Desjardins D, Lachaine J . Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma. 2009; 18(3):238-43. DOI: 10.1097/IJG.0b013e3181815421. View

11.

Bae H, Lee N, Lee H, Hong S, Seong G, Kim C . Systemic hypertension as a risk factor for open-angle glaucoma: a meta-analysis of population-based studies. PLoS One. 2014; 9(9):e108226. PMC: 4177901. DOI: 10.1371/journal.pone.0108226. View

12.

Ramakrishnan R, Nirmalan P, Krishnadas R, Thulasiraj R, Tielsch J, Katz J . Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003; 110(8):1484-90. DOI: 10.1016/S0161-6420(03)00564-5. View

13.

Krishnaiah S, Kovai V, Srinivas M, Shamanna B, Rao G, Thomas R . Awareness of glaucoma in the rural population of Southern India. Indian J Ophthalmol. 2005; 53(3):205-8. DOI: 10.4103/0301-4738.16685. View

14.

Mitchell P, Lee A, Rochtchina E, Wang J . Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma. 2004; 13(4):319-26. DOI: 10.1097/00061198-200408000-00010. View

15.

Lacey J, Cate H, Broadway D . Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 2008; 23(4):924-32. DOI: 10.1038/eye.2008.103. View

16.

Quigley H, Broman A . The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3):262-7. PMC: 1856963. DOI: 10.1136/bjo.2005.081224. View